Thermo Fisher Scientific UBE2E3 Monoclonal Antibody (OTI1C3), TrueMAB

Applications

Tested Application

• Western Blot (WB): 1:2,000 dilution

Product Specifications

Target Information

The ubiquitin (Ub) pathway involves three sequential enzymatic steps that facilitate the conjugation of Ub and Ub-like molecules to specific protein substrates.

1. The first step requires the ATP-dependent activation of the Ub C-terminus and assembly of multi-Ub chains by the Ub-activating enzyme (E1).
2. The Ub chain is then conjugated to the Ub-conjugating enzyme (E2) to generate an intermediate Ub-E2 complex.
3. The Ub-ligase (E3) catalyzes the transfer of Ub from E2 to the appropriate protein substrate.

UBE2E3 (also known as UBCH9) catalyzes the covalent attachment of ubiquitin to other proteins and is involved in regulating transepithelial sodium transport in renal cells. It may also play a role in cell growth arrest. UBE2E3 shuttles between the cytoplasm and nucleus in an IPO11-dependent manner and is ubiquitously expressed at low levels, with high expression in skeletal muscle.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.